B+
Bull case
20%
Probability
Target price
$14.00
Analysis reference price unavailable
Analysis 2026-08-01 · RankAlpha Sentiment Codex
BIOA
BioAge LabsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Positive Phase 1 BGE-102 biomarker reductions and tolerability, combined with the completed $132.3 million follow-on offering, support execution through multiple proof-of-concept milestones [#SEC-8K-2026-05-08].
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +7.5.
What can break
Biomarker improvements may not translate into patient outcomes or durable commercial value.
Momentum
1
Value
41
Sentiment
64
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $9.50 · Bull $14.00 · Bear $5.50Analysis 2026-08-01; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-01 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $35.63
Why
Momentum1 · Δ7d -0.1
Value41 · Δ7d 0.0
Sentiment64 · Δ7d +7.5
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +7.5.
Contradictions & invalidation
- • Biomarker improvements may not translate into patient outcomes or durable commercial value.
- • Clinical and regulatory outcomes remain binary, with no confirmed clinical efficacy yet.
- • BIOA remains a pre-proof-of-concept clinical biotech.
Catalyst clock
2026-08-31
Near-term sentiment and insider-sale overhang
Lead driver: Sentiment · See AI snapshot
Momentum
1
9% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.2
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
-5.2
Sentiment
64
62% active weight
Current posture
7d trendImproving
Δ7d
+7.5
Δ21d
+14.8
Why this grade
Composite grade D. Momentum 1.3 / Value 41.2 / Sentiment 64.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-01. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$9.50
Analysis reference price unavailable
Analysis 2026-08-01 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$5.50
Analysis reference price unavailable
Analysis 2026-08-01 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$477.33M
Beta
-
Shares Out
45.9M
P/E (TTM) · Derived
-4.6
P/S (TTM)
-
P/FCF (TTM) · Derived
-4.65
Rev YoY
+1.6%
EPS YoY
-3.2%
Gross Margin
+97.6%
Op Margin
-1026.3%
Net Debt
-$275.54M
Current Ratio
17.19
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data